Can Naftidrofuryl Cause Hypotension?
Yes, naftidrofuryl can cause hypotension, though this adverse effect is reported rarely in the literature. The most commonly reported side effects are mild gastrointestinal disorders, not cardiovascular effects 1.
Evidence for Hypotension Risk
The clearest evidence comes from a human study measuring cochlear blood flow during acoustic neurinoma surgery. When naftidrofuryl 200 mg was given as an intravenous bolus, it provoked:
- Significant decrease in systolic arterial pressure (-13.7 ± 4%)
- Significant decrease in cochlear blood flow (-14.5 ± 7.55%)
- Compensatory increase in heart rate (+8.5 ± 3.5%)
The mechanism appears to be direct vasodilation, similar to sodium nitroprusside, with a strong correlation between blood flow reduction and blood pressure drop (r = 0.88) 2.
Clinical Context and Frequency
Hypotension is listed as a rare side effect in case reports of naftidrofuryl use 3. The European Society of Cardiology guidelines, which extensively review naftidrofuryl for intermittent claudication, identify mild gastrointestinal disorders as the most frequently observed side effect, with no mention of hypotension as a common concern 1.
Important Clinical Considerations
- Route matters: The hypotensive effect was documented with intravenous administration 2. Oral naftidrofuryl (the standard formulation for peripheral arterial disease) may have different hemodynamic effects
- Dose-dependent: The vasodilatory effect appears related to bolus dosing (200 mg IV) rather than standard oral maintenance therapy
- Mechanism: As a 5-HT2 receptor antagonist, naftidrofuryl causes vasodilation, which theoretically could lower blood pressure 1, 4
Practical Recommendations
Monitor blood pressure when initiating naftidrofuryl, particularly:
- In patients already on antihypertensive medications
- In elderly or volume-depleted patients
- When using intravenous formulations (though IV naftidrofuryl was withdrawn in 1995 due to reported side effects) 5
The risk of hypotension should not prevent use of oral naftidrofuryl for appropriate indications (intermittent claudication), as it remains a well-tolerated medication with predominantly gastrointestinal side effects in clinical practice 1.